Last reviewed · How we verify
Miralax-Gatorade Prep — Competitive Intelligence Brief
marketed
Osmotic laxative bowel preparation agent
Gastroenterology
Small molecule
Live · refreshed every 30 min
Target snapshot
Miralax-Gatorade Prep (Miralax-Gatorade Prep) — VA Office of Research and Development. Miralax-Gatorade Prep is an osmotic laxative combined with an electrolyte solution that draws water into the bowel to promote bowel evacuation.
Comparator set (2 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Miralax-Gatorade Prep TARGET | Miralax-Gatorade Prep | VA Office of Research and Development | marketed | Osmotic laxative bowel preparation agent | ||
| Polyethylene glycol + ascorbate | Polyethylene glycol + ascorbate | Parc de Salut Mar | marketed | Osmotic laxative bowel preparation agent | ||
| Moviprep(1-day treatment) | Moviprep(1-day treatment) | Nihon Pharmaceutical Co., Ltd | phase 3 | Osmotic laxative bowel preparation agent |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Osmotic laxative bowel preparation agent class)
- Nihon Pharmaceutical Co., Ltd · 1 drug in this class
- Parc de Salut Mar · 1 drug in this class
- VA Office of Research and Development · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Miralax-Gatorade Prep CI watch — RSS
- Miralax-Gatorade Prep CI watch — Atom
- Miralax-Gatorade Prep CI watch — JSON
- Miralax-Gatorade Prep alone — RSS
- Whole Osmotic laxative bowel preparation agent class — RSS
Cite this brief
Drug Landscape (2026). Miralax-Gatorade Prep — Competitive Intelligence Brief. https://druglandscape.com/ci/miralax-gatorade-prep. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing